Huntingtons sjukdom

1. Harper PS. The epidemiology of Huntington's disease. Hum Genet 1992; 89: 365-76. PubMed  
2. Folstein SE, Chase GA, Wahl WE et al. Huntington's disease in Maryland: clinical aspects and racial variation. Am J Hum Genet 1987; 41: 168-79. PubMed  
3. Heiberg A. Huntingtons sykdom. Tidsskr Nor Legeforen 2008; 128: 2214-7. Tidsskrift for Den norske legeforening  
4. Dietrichs E, Tallaksen CME. Genetikk ved bevegelsesforstyrrelser - dystoni, tremor og chorea. Tidsskr Nor Lægeforen 2004; 124: 2236-7. Tidsskrift for Den norske legeforening  
5. SuttonBrown M, Suchowersky O. Clinical and research advances in Huntington's disease. Can J Neurol Sci 2003; 30 (suppl 1): 45-52.
6. Helle JR, Braathen GJ, Skodje T, Berg K. Diagnostisk DNA-testing for Huntingtons sykdom. Tidsskr Nor Lægeforen 2000; 120: 2408-10. Tidsskrift for Den norske legeforening  
7. Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 2006; 66: 366-72. PubMed  
8. Huntington Study Group TREND-HD Investigators. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol 2008; 65: 1582-9. PubMed  
9. Roos RA, Hermans J, van der Vegter V, van Ommen GJ, Bruyn GW. Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993; 56: 98-100. PubMed  
10. Helle JR, Braathen GJ, Pedersen JC et al. Genetisk veiledning ved presymptomatisk testing for Huntingtons sykdom Tidsskr Nor Lægeforen 2000; 120: 2412-6. PubMed  

• Håkan Widner, adj professor och överläkare, Neurologiska kliniken, Skånes universitetssjukhus

Tidigare sakkunniga

• Espen Dietrichs, professor och avdelningsöverläkare, Universitetet i Oslo og Nevrologisk avdeling, Rikshospitalet, Oslo
• Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim